Actively Recruiting

Phase Not Applicable
Age: 18Years - 50Years
FEMALE
NCT07535190

Endometrial Immune Profile Changes After Autologous Intrauterine PRP Treatment

Led by Nadezhda Women's Health Hospital · Updated on 2026-04-17

50

Participants Needed

1

Research Sites

123 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The success rate after treatment by in-vitro fertilisation (IVF) strongly depends on the endometrial receptivity, which in turn is strictly connected to the endometrial immune profile. IVF outcome is largely dependent upon endometrial immune cell ratios and their relationship with one another. During the last few years there are several studies and case reports for intrauterine PRP application in patients resulting in a thicker, regenerated endometrium and better immune cell population ratios. In this project, the investigators aim to analyze the effect of autologous intrauterine PRP administration on the endometrial immune profile, endometrial thickness, selected hormone levels (E2, P4) during the mid-luteal phase and IVF outcomes (biochemical and clinical pregnancy).

CONDITIONS

Official Title

Endometrial Immune Profile Changes After Autologous Intrauterine PRP Treatment

Who Can Participate

Age: 18Years - 50Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Participating in Assisted Reproduction Treatment
  • Having infertility
  • Having regular menstrual cycles
  • Embryo transfer of euploid embryos
Not Eligible

You will not qualify if you...

  • Uterine pathologies
  • Endometrial Bacterial infections
  • Active endometrial inflammation
  • Polycystic ovary syndrome
  • Cancer diagnostics
  • Positive HIV, HCV or HBV tests
  • Autoimmune diseases
  • Recent immune therapy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Nadezhda Women's Health Hospital

Sofia, Sofia, Bulgaria, 1330

Actively Recruiting

Loading map...

Research Team

G

Georgi Stamenov, MD

CONTACT

D

Dimitar Parvanov, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Endometrial Immune Profile Changes After Autologous Intrauterine PRP Treatment | DecenTrialz